4//SEC Filing
TZIANABOS ARTHUR 4
Accession 0000950170-24-096986
CIK 0001661998other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:05 PM ET
Size
8.7 KB
Accession
0000950170-24-096986
Insider Transaction Report
Form 4
Q32 Bio Inc.QTTB
TZIANABOS ARTHUR
Director
Transactions
- Exercise/Conversion
Common Stock
2024-03-25+1,095→ 8,248 total - Sale
Common Stock
2024-03-25$24.20/sh−265$6,413→ 7,983 total - Exercise/Conversion
Restricted Stock Units
2024-03-25−1,095→ 0 total→ Common Stock (1,095 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer Common Stock.
- [F2]The Issuer effected a 1-for-18 reverse stock split of its Common Stock on March 25, 2024. The amounts reported on this Form 4 have been adjusted to reflect the reverse stock split.
- [F3]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
- [F4]The restricted stock units vested in three equal installments, with the final installment vested on March 25, 2024. The restricted stock units had no expiration date.
Documents
Issuer
Q32 Bio Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001586226
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:05 PM ET
- Size
- 8.7 KB